Levacetylmethadol

DB01227ApprovedWithdrawnSmall molecule

Levacetylmethadol is a narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. Levacetylmethadol was withdrawn from use in the... Levacetylmethadol was withdrawn from use in the European Union due to its high risk of QT interval prolongation.

Chemical structure of Levacetylmethadol
Mechanism
Curator reviewed
Primary indication
For the treatment and management of opiate dependence.Curator reviewed
Formula / weight
C23H31NO2 · 353.4977 g/mol (avg)
Also known as
1-alpha-Acetylmethadol · LAAM · Levo-alpha-acetylmethadol · Levo-methadyl acetate · Levomethadyl

Resolves to

Structure
InChIKeyXBMIVRRWGCYBTQ-AVRDEDQJSA-NSMILESCC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,567Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2Marketed productsAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 23 drug categories
Sign in
14+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Levacetylmethadol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account